11.53  0 (0%)		09-12 16:00
Open: 11.32 High: 11.53 Volume: 3,520		Pre. Close: 11.53 Low: 11.32 Market Cap: 90(M)

Short term
Mid term
Targets	6-month :	13.46	1-year :	15.72
Resists	First :	11.52	Second :	13.46
Pivot price	11.26
Supports	First :	11.33	Second :	11.21
MAs	MA(5) :	11.34	MA(20) :	11.26
	MA(100) :	11.31	MA(250) :	11.11
MACD	MACD :	0	Signal :	-0.1
%K %D	K(14,3) :	100	D(3) :	90.7
RSI	RSI(14): 85.6
52-week	High :	13.69	Low :	10.06

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ PWUP ] has closed Bollinger Bands are 15.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	11.54 - 11.59	11.59 - 11.63
Low:	11.19 - 11.25	11.25 - 11.3
Close:	11.43 - 11.52	11.52 - 11.6

PowerUp Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business within the interactive media, digital media, sports, entertainment, and/or leisure areas. The company was incorporated in 2021 and is based in New York, New York.

Wed, 11 Sep 2024
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of DECA, PWUP and EVGR - AccessWire

Tue, 10 Sep 2024
PowerUp Acquisition (NASDAQ:PWUP) Trading 0.5% Higher - MarketBeat

Tue, 10 Sep 2024
PowerUp Acquisition (NASDAQ:PWUP) Trading 0.5% Higher - Defense World

Wed, 04 Sep 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPXX, PWUP, DECA, TTNP on Behalf of Shareholders - Longview News-Journal

Tue, 03 Sep 2024
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements - StockTitan

Wed, 24 Jul 2024
PowerUp Acquisition Corp ends merger agreement with Visiox By Investing.com - Investing.com Australia

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	8 (M)
Shares Float	1 (M)
Held by Insiders	92.5 (%)
Held by Institutions	8.8 (%)
Shares Short	1 (K)
Shares Short P.Month	1 (K)

EPS	-0.29
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.76
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-17.1 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-3 (M)
Levered Free Cash Flow	-2 (M)

PE Ratio	-41.18
PEG Ratio	0
Price to Book value	-15.18
Price to Sales	0
Price to Cash Flow	-28.63

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.